Home/Filings/4/0001209191-23-021859
4//SEC Filing

Skvarka Jan 4

Accession 0001209191-23-021859

CIK 0001826457other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 4:15 PM ET

Size

5.4 KB

Accession

0001209191-23-021859

Insider Transaction Report

Form 4
Period: 2023-03-30
Skvarka Jan
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-03-30+41,00041,000 total
    Exercise: $7.36Exp: 2033-03-29Common Stock (41,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in 36 substantially equal monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.

Issuer

Monte Rosa Therapeutics, Inc.

CIK 0001826457

Entity typeother

Related Parties

1
  • filerCIK 0001838042

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:15 PM ET
Size
5.4 KB